CD274 and cancer: Moreover, additional biomarkers, including tumor-derived exosomes, immune checkpoint molecules such as programmed cell death ligand 1 (PD-L1) [96], and aging-associated microRNA (e.g., miR-146a, miR-21) [97], have been effective in the diagnosis or treatment of cancer patients.